Heron Therapeutics (AXD2) Cash flow

4 Followers

Heron Therapeutics Cash Flow

DE:AXD2's free cash flow for Q2 2026 was $-2.35M. For the 2026 fiscal year, DE:AXD2's free cash flow was decreased by $-3.67M and operating cash flow was $-2.21M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -27.59M	$ -22.53M	$ -58.79M	$ -146.91M	$ -203.35M
Investing Cash Flow	$ 16.01M	$ 18.71M	$ 18.00M	$ -3.32M	$ 32.73M
Financing Cash Flow	$ 14.43M	$ 940.00K	$ 54.11M	$ 75.06M	$ 156.03M
End Cash Position	$ 28.65M	$ 25.80M	$ 28.68M	$ 15.36M	$ 90.54M
Free Cash Flow	$ -27.91M	$ -24.23M	$ -60.33M	$ -148.74M	$ -206.38M

Currency in USD